Knowledge Sharing & Fostering Discussion
WGNV shares knowledge and information about TB vaccine R&D and provides a platform for discussion on key issues, concepts, and gaps. Our activities include organizing workshops, compiling a pipeline of TB vaccine candidates in development, convening the Global Forum on TB Vaccines, and sharing resources and information via our website and mailing list.
Workshops
WGNV works with partners to organize workshops on topics of interest to TB vaccine R&D.
Check out our most recent workshops below.
RECOGNITION AND CONTROL OF MTB INFECTED CELLS: FROM BASICS TO THE CLINIC
June 13 - 14, 2023
The WGNV and the National Institute for Allergy and Infectious Diseases (NIAID) co-hosted this workshop to address the need for correlates and to identify platforms that measure recognition or control of the infected cell - especially in humans.
Bridging the gap: Evaluating high TB burden country data needs to support the potential introduction of TB vaccines for adolescents and adults
October 6, 2023
The WGNV and the London School of Hygiene & Tropical Medicine (LSHTM) convened this workshop to ask high burden country experts about what epidemiological, impact, feasibility and acceptability data they need to inform the introduction of new TB vaccines.
TB Vaccine Pipeline
The TB Vaccine Pipeline tracks the research and development of TB vaccine candidates through different phases of development, from pre-clinical to late-stage testing.
Global Forum on TB Vaccines
The Global Forum on TB Vaccines is the world’s largest gathering of stakeholders striving to develop new vaccines to prevent TB. It provides a unique opportunity to review the state of the field, share the latest research and findings, and identify new and innovative approaches to TB vaccine R&D, with the end goal of developing and deploying new TB vaccines as quickly as possible. To date, six Global Forums and one virtual edition have been held, beginning with the first Global Forum in Geneva, Switzerland in 2001 (convened by WHO). The Working Group on New TB Vaccines convenes the Global Forum in collaboration with IAVI, the TuBerculosis Vaccine Initiative, and host country partner organizations.
For the first time ever, the Global Forum on TB Vaccines will be hosted in the Americas, under the theme Driving innovation from discovery to access. Don't miss this opportunity to gather with the TB vaccine research and development community in Rio de Janeiro, Brazil from 8-10 October to discuss the latest in TB vaccine R&D.
INAUGURAL ANNUAL WGNV MEETING
Tuesday, 14 November 2023 | Paris, France
The Stop TB Partnership Working Group on New TB Vaccines (WGNV) held its first annual meeting on 14 November 2023. The meeting was part of a full-day New TB Tools Summit – a collaboration between WGNV, the Stop TB Partnership’s Working Group on New Drugs and New Diagnostics Working Group, TB Alliance, FIND, and IAVI – held just in advance of the 53rd Union World Conference on Lung Health. We were delighted to have so many participants attend the meeting and express interest in our work and the research and development of new TB vaccines.
The meeting had three main parts: an introduction to the WGNV, an overview of the state of the field, and a panel discussion on key topics in TB vaccine R&D.